Literature DB >> 10740992

Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.

L Sevincok, A Uslu, H Kaynak, F Dereboy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10740992      PMCID： PMC1408066     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  7 in total

1.  Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.

Authors:  C J McDougle; W K Goodman; L H Price; P L Delgado; J H Krystal; D S Charney; G R Heninger
Journal:  Am J Psychiatry       Date:  1990-05       Impact factor: 18.112

Review 2.  Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?

Authors:  W K Goodman; C J McDougle; L H Price; M A Riddle; D L Pauls; J F Leckman
Journal:  J Clin Psychiatry       Date:  1990-08       Impact factor: 4.384

3.  Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders.

Authors:  D J Stein; C Bouwer; S Hawkridge; R A Emsley
Journal:  J Clin Psychiatry       Date:  1997-03       Impact factor: 4.384

4.  Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.

Authors:  C J McDougle; W K Goodman; J F Leckman; N C Lee; G R Heninger; L H Price
Journal:  Arch Gen Psychiatry       Date:  1994-04

5.  Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.

Authors:  E L Weiss; M N Potenza; C J McDougle; C N Epperson
Journal:  J Clin Psychiatry       Date:  1999-08       Impact factor: 4.384

6.  A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.

Authors:  M A Jenike; S Hyman; L Baer; A Holland; W E Minichiello; L Buttolph; P Summergrad; R Seymour; J Ricciardi
Journal:  Am J Psychiatry       Date:  1990-09       Impact factor: 18.112

7.  Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.

Authors:  G Alfredsson; C Härnryd; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.